Boston, MA -- (SBWIRE) -- 11/01/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Minerco Resources Inc(OTCMKTS:MINE), BP plc (ADR)(NYSE:BP), Inovio Pharmaceuticals Inc(NYSEMKT:INO), Merrimack Pharmaceuticals Inc(NASDAQ:MACK)
Minerco Resources Inc(OTCMKTS:MINE) opened its shares at the price of $0.0033 for the day. Its closing price was $0.0036 after gaining +16.13% for the day. The company traded with the total volume of 57.56 million shares, while its average trading volume remained 27.09 million shares. The beta of MINE stands at -18.02.
Minerco Resources, Inc. is a development-stage company. The Company is a progress developer, producer and provider of clean, renewable energy solutions in Latin America.
For How Long MINE will Fight for Profitability? Read This Trend Analysis report
BP plc (ADR)(NYSE:BP) percentage change surged +0.45% to close at $46.50 with the total traded volume of 2.200 shares, and average volume of 5.75 million. The 52 week range of the stock remained $39.58 - $46.65, while its day lowest price was $46.22 and it hit its day highest price at $46.65.
BP p.l.c. (BP) is an integrated oil and gas company. The Company provides its customers with fuel for transportation, energy for heat and light, lubricants and the petrochemicals products used to make everyday items as diverse as paints, clothes and packaging.
For How Long BP Gloss will Attract Investors? Find out via this report
Inovio Pharmaceuticals Inc(NYSEMKT:INO) started its trading session with the price of $1.77 and closed at $1.73 by losing -3.35%. INO stocks traded with total volume of 5.26 million shares, while the average trading volume remained 4.29 million shares. The beta of INO stands at 3.32. Day range of the stock was $0.44 -$3.03.
Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases.
Why Should Investors Buy INO After the Recent Fall? Just Go Here and Find Out
Merrimack Pharmaceuticals Inc(NASDAQ:MACK) ended its day with the loss of -2.19% and closed at the price of $2.68 after opening at $2.74. Stock traded during its last trading session with the total volume of 1.70 million shares, as compared to its average volume of 1.30 million shares.
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer.
Will MACK Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)